Teriparatide 560MCG/2.24ML pen 2.24ML
Ended Awarded
- Contract number
- SPE2DB25FS4XW
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $5,560
Award facts
- Contract value 100% obligated
- $5,560.39 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of Teriparatide 560 mcg/2.24 mL pen injections, with a ceiling value of $5,560.39. This is a firm fixed-price delivery order with an ultimate completion date of May 9, 2025, and represents a non-competitive set-aside award. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion agreement running through December 2026 that serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has demonstrated extensive capability in fulfilling federal medical procurement requirements through its broad portfolio of pharmaceutical deliveries to military and veteran healthcare systems. The company consistently wins competitively awarded contracts with the Defense Logistics Agency, supplying diverse medical commodities including specialty medications, brand-name and generic drugs, and specialized medical supplies. This particular teriparatide delivery supports osteoporosis treatment needs within the Defense Health Agency and military healthcare system, leveraging AmerisourceBergen's established capacity to deliver critical pharmaceutical products on an expedited timeline.
Quick answers
Who was awarded contract SPE2DB25FS4XW?
SPE2DB25FS4XW was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on May 8, 2025.
How much is contract SPE2DB25FS4XW worth?
The government has obligated $5,560 on SPE2DB25FS4XW.
Is contract SPE2DB25FS4XW an order under another contract?
Yes. SPE2DB25FS4XW is a delivery order under SPE2DB22D2214, an indefinite delivery contract.
Was contract SPE2DB25FS4XW competed?
The extent of competition for SPE2DB25FS4XW was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award